Insider Cluster (2 insiders) ·Filed Sep 2, 2026

NRIX

Nurix Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed29d 19h ago
Insider cluster: 2 insiders, $175K total
Actionable Insight • Neutral

No material signal from this cluster. The small dollar amounts and concurrent option exercises suggest routine tax-related selling. Monitor for larger insider transactions (>0.5% of market cap) or a cluster of open-market purchases for a directional read.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d
NRIX ▼ -0.87% at T+5d
NEUTRAL call ✗ call lost -0.87% · α vs SPY +0.28% · entry $25.32 → $25.10
Next anchor: T+20d due yesterday
Latest observation: T+19 -12.87% FF3 residual α
Entry anchored
Sep 2, 2026
via day open
T+1d
+3.24%
call +3.24% · α +3.62%
$26.14
settled 29d ago
T+5d
-0.87%
call -0.87% · α +0.28%
$25.10
settled 22d ago
T+20d
—
call — · α —
—
due yesterday
T+60d
—
call — · α —
—
in 8w

Price Chart

Loading chart...

Executive Summary

Two C-suite insiders at Nurix Therapeutics (NRIX) — Chief Scientific Officer Gwenn Hansen and Chief Legal Officer Christine Ring — sold a combined $175K in open-market transactions over a 2-day window. The total represents ~0.0065% of the company's $2.7B market cap, making the cluster economically trivial and likely driven by routine tax withholding or option-exercise-related sales.

Key Financial Metrics

Direction
selling
Total Value
$175.0K
Insiders
2

Key Facts

  • Chief Scientific Officer Gwenn Hansen sold 1,452 shares at $25.47 for $36,982 on 2026-09-01.
  • Chief Legal Officer Christine Ring sold 5,787 shares at $25.69 for $138,417 on 2026-09-02 (includes 400 shares at $26.64).
  • Both insiders also exercised derivative securities (non-cash) on the same dates, consistent with option-exercise-and-sell patterns.
  • Total insider sales of $175K represent ~0.0065% of NRIX's $2.7B market cap — well below the 0.1% materiality threshold.

Financial Impact

Two C-suite insiders sold $175K total, representing ~0.0065% of market cap — trivial and non-material.

insider activity

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NRIX-1788392609018
18 reports for NRIX
Performance horizon
60% Hit rate 3 of 5 directional calls best @ T+20▲ +53.71%Jun 8, 2026
Filters
Rows
Reports for NRIX — sortable, filterable
TypeNow
Sep 2, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$25.32 $25.10▼ −0.87%▲ +0.28%$22.89 (−9.60%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$25.22 $27.19▲ +7.81%▲ +6.60%$22.89 (−9.24%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$25.12 $26.63▲ +6.01%▲ +5.66%$22.89 (−8.88%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$25.12 $26.63▲ +6.01%▲ +5.66%$22.89 (−8.88%)
Aug 3, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.69 $25.96▲ +5.14%▲ +5.24%$22.89 (−7.29%)
Jul 30, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$23.21 $25.53▲ +10.00%▲ +6.48%$22.89 (−1.38%)
Jul 9, 2026
12w ago
Press Release
BULLISH ★ 8/10
$23.06 $23.07▲ +0.04%▲ +0.60%$22.89 (−0.74%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$23.97 $24.69▲ +3.00%▲ +2.07%$22.89 (−4.51%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 4/10
$16.98 $17.12▲ +0.82%▲ +0.39%$22.89 (+34.81%)
Jun 8, 2026
16w ago
8-K
BULLISH ★ 8/10
$15.64 $17.04▲ +8.95%▲ +6.84%$22.89 (+46.36%)
Showing 10 of 18

US Market Status

Market Open — Closes in 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Sep 2, 2026